Sanofi on Monday acquired the rights to Afrezza Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with Type 1 and Type 2 diabetes, from MannKind in a deal that could be worth as much as $925 million.
Procter & Gamble’s Braun has unveiled a new branding campaign, dubbed #FaceGreatness with Braun Confidence, featuring NFL and Braun’s new U.S. spokesperson, Seattle Seahawks Super Bowl quarterback, Russell Wilson.
As a sponsor of the Washington, D.C. tour stop for 'Oprah's The Life You Want Weekend,' Giant Food of Landover on Monday offered customers the exclusive opportunity to attend the transformational weekend September 19-20 at the Verizon Center in Washington, D.C., in partnership with Procter & Gamble.
The National Retail Federation, Retail Industry Leaders Association, Food Marketing Institute, Merchant Advisory Group, National Association of Convenience Stores, National Grocers Association, and National Restaurant Association are jointly calling for an open and universal tokenization standard in the U.S. payments system.
Industry consolidation continues as CVS Caremark has entered an agreement to snap up regional player Navarro Discount Pharmacy — a move that makes sense for CVS Caremark on several fronts.
Not only does the acquisition strengthen CVS Caremark’s position in the Hispanic marketplace, the fastest growing demographic in the United States, but the deal also includes Navarro Health Services, a specialty pharmacy serving those with complex diseases.
GSK has begun shipping Fluarix Quadrivalent (influenza vaccine) doses to U.S. healthcare providers, the company annouced. This marks the first shipment of GSK's U.S. flu vaccine supply for the flu season, which follows licensing and lot-release approval from the Food and Drug Administration's Center for Biologics Evaluation and Research.
The 2014 United States of Aging Survey released Tuesday found that Americans aged 60 years and older report they are more motivated than the past two years to improve their health by exercising regularly and setting health goals — two simple steps which also relate to reported increases in optimism among seniors.
Although the pace of approvals for new orphan drugs — medicines that treat relatively rare conditions — have increased in the United States and Europe in recent years, patients are facing growing challenges accessing those drugs, a newly completed study released last week by the Tufts Center for the Study of Drug Development at Tufts University has concluded.